The following tables relate only to registered shareholders and cannot be assumed to represent the entire investor base because nominees and JPMorgan Chase Bank, N.A., as ADS depositary, are registered as shareholders for a large number of beneficial owners.

As of December 31, 2022, Novartis AG had approximately 186 000 registered shareholders

Registered shareholders by type

As of December 31, 2022 Shareholders in % Shares in %
Individual shareholders 96.71 15.61
Legal entities1 3.25 37.69
Nominees, fiduciaries and ADS depositary 0.04 46.70

 

Registered shareholders by country2

As of December 31, 2022 Shareholders in % Shares in %
Belgium 0.11 0.77
France 1.97 0.36
Germany 5.72 1.82
Japan 0.17 0.45
Luxembourg 0.06 0.79
Switzerland1 87.14 48.39
United Kingdom 0.63 23.68
United States 0.25 21.29
Other countries 3.95 2.45

 

  1. Excluding 7.7% of the share capital held as treasury shares by Novartis AG or its fully owned subsidiaries. As of the entry into force of the revised Swiss Code of Obligations on January 1, 2023, Novartis ordinary shares held by certain Swiss foundations controlled by Novartis also no longer carry the right to vote and therefore will be treated for this calculation as treasury shares going forward.
  2. Registered shares held by nominees are shown in the country where the company/affiliate entered in the Share Register as shareholder has its registered seat.